November 4, 2024

Mushrooms hit the ballots as researchers grapple with the dangers of psychedelics

(Washington Times) – Massachusetts could become the third U.S. state to decriminalize psilocybin, the psychedelic drug found in mushrooms, if enough state voters mark “yes” on their ballot’s Question 4. Many drug policy researchers say legalization could be dangerous because … Read More



 
 

November 1, 2024

From A.I. to Musk’s Brain Chips, the F.D.A.’s Device Unit Faces Rapid Change

(New York Times) – The new director overseeing medical devices will confront criticisms about hasty approvals as she ushers in revolutionary technology. Medical device technology is now deeply entrenched in many patients’ health care and can have a stunning impact … Read More



 
 

October 31, 2024

Key global bioethics guidelines get ‘dramatic’ update

(Science) – Revised Declaration of Helsinki stresses need for equity, protection of vulnerable groups, and research integrity The Declaration of Helsinki—a foundational text that outlines international ethical principles for medical research—has undergone one of the most extensive revisions since it … Read More



 
 

October 30, 2024

A Woman Died After Being Told It Would Be a “Crime” to Intervene in Her Miscarriage at a Texas Hospital

(ProPublica) – Barnica is one of at least two Texas women who ProPublica found lost their lives after doctors delayed treating miscarriages, which fall into a gray area under the state’s strict abortion laws that prohibit doctors from ending the … Read More



 
 

October 29, 2024

Anti-Obesity Medications Show Whole-Body Promise, With More to Come

(Medscape) – The potential of glucagon-like peptide 1 (GLP-1) receptor agonists continues to grow more promising as new studies identify benefits beyond glucose control and weight loss. With hundreds of studies underway or recently completed on ClinicalTrials.gov, the signals are … Read More